<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28528761</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>36</Issue><PubDate><Year>2017</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities.</ArticleTitle><Pagination><StartPage>4769</StartPage><EndPage>4776</EndPage><MedlinePgn>4769-4776</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2017.04.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(17)30514-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">The European Region, certified polio-free in 2002, remains at risk of wild poliovirus reintroduction and emergence of circulating vaccine-derived polioviruses (cVDPV) until global polio eradication is achieved, as demonstrated by the cVDPV1 outbreak in Ukraine in 2015.</AbstractText><AbstractText Label="METHODS">We reviewed epidemiologic, clinical and virology data on cVDPV cases, surveillance and immunization coverage data, and reports of outbreak-related surveys, country missions, and expert group meetings.</AbstractText><AbstractText Label="RESULTS">In Ukraine, 3-dose polio vaccine coverage declined from 91% in 2008 to 15% by mid-2015. In summer, 2015, two unrelated children from Zakarpattya province were paralyzed by a highly divergent cVDPV1. The isolates were 20 and 26 nucleotide divergent from prototype Sabin strain (with 18 identical mutations) consistent with their common origin and &#x223c;2-year evolution. Outbreak response recommendations developed with international partner support included conducting three nationwide supplementary immunization activities (SIAs) with tOPV, strengthening surveillance and implementing communication interventions. SIAs were conducted during October 2015-February 2016 (officially reported coverage, round 1-64.4%, round 2-71.7%, and round 3-80.7%). Substantial challenges to outbreak response included lack of high-level support, resistance to OPV use, low perceived risk of polio, widespread vaccine hesitancy, anti-vaccine media environment, economic crisis and military conflict. Communication activities improved caregiver awareness of polio and confidence in vaccination. Surveillance was enhanced but did not consistently meet applicable performance standards. Post-outbreak assessments concluded that cVDPV1 transmission in Ukraine has likely stopped following the response, but significant gaps in population immunity and surveillance remained.</AbstractText><AbstractText Label="CONCLUSIONS">Chronic under-vaccination in Ukraine resulted in the accumulation of children susceptible to polioviruses and created favorable conditions for VDPV1 emergence and circulation, leading to the outbreak. Until programmatic gaps in immunization and surveillance are addressed, Ukraine will remain at high-risk for VDPV emergence and circulation, as well as at risk for other vaccine-preventable diseases.</AbstractText><CopyrightInformation>Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khetsuriani</LastName><ForeName>Nino</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for Europe, Copenhagen, Denmark; Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: nck7@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perehinets</LastName><ForeName>Ihor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ministry of Health of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nitzan</LastName><ForeName>Dorit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office in Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popovic</LastName><ForeName>Dragoslav</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UNICEF Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moran</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allahverdiyeva</LastName><ForeName>Vusala</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office in Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huseynov</LastName><ForeName>Shahin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for Europe, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavrilin</LastName><ForeName>Eugene</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for Europe, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slobodianyk</LastName><ForeName>Liudmyla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office in Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izhyk</LastName><ForeName>Olha</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office in Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sukhodolska</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UNICEF Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegazi</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UNICEF Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulavinova</LastName><ForeName>Katerina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>UNICEF Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platov</LastName><ForeName>Sergei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ministry of Health of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for Europe, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023321">Poliovirus Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023321" MajorTopicYN="N">Poliovirus Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014455" MajorTopicYN="N">Ukraine</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072758" MajorTopicYN="N">Vaccination Refusal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Circulating vaccine-derived poliovirus (cVDPV) outbreak</Keyword><Keyword MajorTopicYN="N">Polio outbreak response</Keyword><Keyword MajorTopicYN="N">Poliomyelitis</Keyword><Keyword MajorTopicYN="N">Supplementary immunization activities (SIA)</Keyword><Keyword MajorTopicYN="N">Ukraine</Keyword><Keyword MajorTopicYN="N">WHO European Region</Keyword></KeywordList><CoiStatement>Conflict of interest. None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28528761</ArticleId><ArticleId IdType="mid">NIHMS1925432</ArticleId><ArticleId IdType="pmc">PMC10465089</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2017.04.036</ArticleId><ArticleId IdType="pii">S0264-410X(17)30514-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. Certification of poliomyelitis eradication. In: Fifteenth meeting of the European regional certification commission, Copenhagen, 19&#x2013;21 June 2002. Copenhagen, Denmark: World Health Organization; 2005. p. 1&#x2013;128.</Citation></Reference><Reference><Citation>Khetsuriani N, Pallansch MA, Jabirov S, et al. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010. Vaccine 2013;31:4911&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10465070</ArticleId><ArticleId IdType="pubmed">23891502</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Pfeifer D, Deshevoi S, et al. Challenges of maintaining polio-free status of the European Region. J Infect Dis 2014;210(Suppl 1):S194&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10465076</ArticleId><ArticleId IdType="pubmed">25316836</ArticleId></ArticleIdList></Reference><Reference><Citation>Anis E, Kopel E, Singer SR, et al.
Insidious reintroduction of wild poliovirus into Israel, 2013. Eurosurveillance
2013;18:2&#x2013;6. &lt;http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20586&gt;. [accessed 28 September 2016].</Citation><ArticleIdList><ArticleId IdType="pubmed">24084337</ArticleId></ArticleIdList></Reference><Reference><Citation>State Statistics Service of Ukraine. Population of Ukraine. &lt;http://database.ukrcensus.gov.ua/PXWEB2007/eng/news/op_popul_e.asp&gt; [accessed 26 November 2016].</Citation></Reference><Reference><Citation>Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees.</Citation><ArticleIdList><ArticleId IdType="pubmed">3447015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K. Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G + C-content biases. Mol Biol Evol 1992;9:678&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">1630306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016;33:1870&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8210823</ArticleId><ArticleId IdType="pubmed">27004904</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. In: Report of the 23rd meeting of the European regional certification commission for poliomyelitis eradication. Copenhagen, Denmark, 28&#x2013;29 June 2010. &lt;http://www.who.int/immunization/sage/2_Polio_RCC23_Final_10_2010.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Report of the 21st meeting of the European regional certification commission for poliomyelitis eradication. Copenhagen, Denmark, 9&#x2013;11 June 2008. &lt;http://www.who.int/immunization/sage/5_EURO_Polio_RCC_Report.pdf&gt;[accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Report of the 22nd meeting of the European regional certification commission for poliomyelitis eradication. Copenhagen, Denmark, 21&#x2013;22 June 2009. &lt;http://www.euro.who.int/__data/assets/pdf_file/0019/92017/E93603.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Standard operating procedures. Responding to a poliovirus outbreak in a polio-free country. February 2015. World Health Organization, 2015. &lt;http://www.polioeradication.org/Portals/0/Document/Resources/PolioEradicators/1a.PolioOutbreakGuideline20150220.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Report of the 30th meeting of the European regional certification commission for poliomyelitis eradication. Sarajevo, Bosnia and Herzegovina, 31 May-2 June 2016. &lt;http://www.euro.who.int/__data/assets/pdf_file/0006/318651/Meeting-report-30th-RCC.pdf?ua=1&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Independent monitoring board of the global polio eradication initiative. Twelfth Report, October, 2015 &lt;http://www.polioeradication.org/Portals/0/Document/Aboutus/Governance/IMB/13IMBMeeting/13IMB_Report_EN.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Independent Monitoring Board of the Global Polio Eradication Initiative. Thirteenth Report, August, 2016. &lt;http://www.polioeradication.org/Portals/0/Document/Aboutus/Governance/IMB/14IMBMeeting/14IMB_Report_EN.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Statement on the 10th IHR Emergency Committee regarding the international spread of poliovirus, August 11, 2016. [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Report of the 26th meeting of the European regional certification commission for poliomyelitis eradication. Copenhagen, Denmark, 18&#x2013;20 June, 2012. &lt;http://www.euro.who.int/__data/assets/pdf_file/0005/184739/e96806.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Polio eradication and endgame strategic plan 2013&#x2013;2018. &lt;http://www.polioeradication.org/Portals/0/Document/Resources/StrategyWork/EndGameStratPlan_20130329_ENG.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Statement on the meeting of the International Health Regulations Emergency Committee concerning the international spread of wild poliovirus, April 28&#x2013;29 2014. &lt;http://www.who.int/mediacentre/news/statements/2014/polio-20140505/en/&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. WHO Guidance for implementation of the IHR Temporary Recommendations under the IHR (2005) to reduce the international spread of polio. November 2015. &lt;http://www.polioeradication.org/Portals/0/Document/Emergency/PolioPHEICguidance.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>World Health Organization. Case definitions for the four diseases requiring notification to WHO in all circumstances under the IHR (2005). &lt;http://www.who.int/ihr/survellance_response/case_definitions/en/&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis 2014;210(Suppl 1):S283&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukrainian Center for Social Reforms, State Statistical Committee of Ukraine, Ministry of Health of Ukraine, and Macro International Inc. 2008. Ukraine Demographic and Health Survey 2007. Calverton, Maryland, USA: UCSR and Macro International. &lt;http://dhsprogram.com/pubs/pdf/FR210/FR210.pdf&gt; [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Lekhan V, Rudiy V, Nolte E. Health care systems in transition: Ukraine. Copenhagen, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies. &lt;http://www.euro.who.int/__data/assets/pdf_file/0010/96418/E84927.pdf&gt;; 2004 [accessed 28 September 2016].</Citation></Reference><Reference><Citation>Wringe A, Fine PE, Sutter RW, Kew OM. Estimating the extent of vaccine-derived poliovirus infection. PLoS ONE 2008;3:e3433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2570794</ArticleId><ArticleId IdType="pubmed">18958288</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R, Kew O, Cochi S, Aylward B. Poliovirus vaccine &#x2013; live. In: Plotkin S, Orenstein W, Offitt P, editors. Vaccines, 6th ed., Elsevier Saunders; 2013. p. 598&#x2013;645.</Citation></Reference><Reference><Citation>Centers for Disease Control. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine &#x2014; Worldwide, 2016. MMWR Wkly; 2016;65:934&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27606675</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Regional Office for Europe. Epidemiological Brief No. 29. &lt;http://www.euro.who.int/__data/assets/pdf_file/0018/181800/EpiBrief-Issue-29.pdf?ua=1&gt;; December, 2012 [accessed September 28, 2016].</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>